Methods and devices for tissue reconfiguration

ABSTRACT

Methods and devices are provided for reconfiguring a tissue within a hollow body organ using an entirely endoscopic approach in order to effectively reduce flow of fluid contents into a second hollow body organ in fluid communication with the first.

FIELD OF THE INVENTION

This invention relates generally to endoscopic methods and devices forreconfiguring tissue within a hollow body organ and more particularly tosuch methods and apparatus used to reduce the reflux of contents of onehollow organ into another hollow organ.

BACKGROUND OF THE INVENTION

Gastroesophageal reflux disease (GERD) is a commonupper-gastrointestinal disorder with a prevalence of approximately 5percent in the Western world. GERD is a condition in which acidiccontents of the stomach flow inappropriately from the stomach into theesophagus. GERD causes heartburn when accompanied by irritation of theesophagus. Chronic irritation of the esophagus leads to inflammation ofthe esophagus, known as esophagitis. In addition to esophagitis,complications of GERD include Barrett's esophagus, esophageal stricture,intractable vomiting, asthma, chronic bronchitis, and aspirationpneumonia. Approximately 25 percent of individuals with GERD failpharmacological therapy and become candidates for a surgical anti-refluxprocedure. The estimated total direct and indirect costs of GERDtreatment in the United States are in excess of 100 billion dollarsannually.

The focus of attention in understanding the pathophysiology of GERD hasfor many years been the lower esophageal sphincter (LES), thought to bea ring of smooth muscle located at the gastroesophageal junction (GEJ)near where the lower esophagus communicates with the entrance to thestomach. Normally the LES allows food to pass from the esophagus to thestomach, while otherwise remaining closed, thus preventing reflux.Closure of the LES is an active process, requiring a combination ofproper mechanics and intact innervation. Additionally, the diaphragm mayact on the esophagus normally to keep it closed at the LES.

Backflow of gastric contents into the esophagus results when gastricpressure is sufficient to overcome the pressure gradient that normallyexists at the GEJ or when gravity acting on the contents is sufficientto cause flow through the GEJ. This situation arises when the gastricpressure is elevated or when the competence of the LES is compromised.Gastric pressure is elevated in association with eating, bending at thewaist or squatting, constriction of the waist by clothing, obesity,pregnancy, partial or complete bowel obstruction, etc. Gravitationaleffects occur when a patient with this condition becomes recumbent.Incompetence of the LES can be functional or anatomic in origin.Functional incompetence is associated with hiatus hernia, denervation,myopathy, scleroderma, and chemical or pharmacological influences(smoking, smooth muscle relaxants, caffeine, fatty foods, andpeppermint). Dodds W J et al., 1982, N Engl J Med 307:1547-52. Anatomicincompetence is associated with congenital malformation, surgicaldisruption (myotomy, balloon dilatation or bouginage), neoplasm, etc.

Recently, the existence and importance of the gastroesophageal flapvalve have come to be appreciated as a significant first line of defenseagainst GERD. Hill L D et al. 1996, Gastrointest Endosc 44:541-7;Contractor Q Q et al. 1999, J Clin Gasroenterol 28:233-7. Thegastroesophageal flap valve appears as a semicircular musculo-mucosalfold extending for 3-4 cm along the lesser curvature of the stomach.

The recent advent of a range of new medications for the treatment ofreflux disease, including omeprazole and other proton pump inhibitors,high-dose histamine-2 antagonists, and cisapride, has markedly improvedthe treatment for many patients. Despite these dramatic advances inmedical therapy for GERD, they are not always fully satisfactory. Thereare cost implications of very long-term treatment of patients with theserelatively expensive medications (Spechler S J 1992, N Engl J Med326:786-92) as well as some concern about the safety of very long-termpotent acid suppression with the possibility of gastrin (G) cellhyperplasia (Solcia E et al. 1993, Aliment Pharmacol Ther 7(supp.1):25-8; Poynter D et al. 1985, Gut 26:1284-95; Lambert R et al. 1993,Gastroenterology 104:1554-7) from prolonged hypergastrinemia.Furthermore, a significant number of patients are resistant to orintolerant of available medical therapy (Klinkenberg-Knol E C andMeuwissen S G 1988 Aliment Pharmacol Ther 2:221-7; Klinkenberg-Knol E Cand Meuwissen S G 1989, Digestion 1:47-53), and many patients relapsequickly if medical treatment is stopped. Hetzel D J et al. 1988,Gastroenterology 95:903-12.

Although several open surgical procedures are effective in the treatmentof GERD, they are now used in a minority of patients because of themajor nature of the surgery and the occasionally poor results achieved.These occasionally poor results may be due in part to the lack of clearpatient selection criteria. At least ten different open antirefluxoperations have been described and used in patients. Jamieson G G, ed.1988, Surgery of the Oesophagus London: Churchill Livingstone, 233-45.The principal types of operations have included some type ofreconstruction of the antirefiux barrier, which may include a gastricwrap, as in classic Nissen fundoplication (Nissen R 1956, Schweiz WedWochenschr 86:590-2; Polk H C et al. 1971, Ann Surg 173:775-81;DeMeester T R et al. 1986. Ann Surg 204:9-20), Toupet fundoplication(Thor K 1988, The modified Toupet procedure, In: Hill L et al., TheEsophagus, Medical and Surgical Management, W B Saunders Co. pp 135-8)or Belsey repair (Skinner D B et al. 1967, J Thorac Cardiovasc Surg53:33-54), a nongastric wrap, e.g., the Angelchik prosthesis (StarlingJR et al. 1982, Ann Surg 195:686-91), a ligamentum teres cardiopexy(Rampal M et al. 1967, Presse Medicule 75:617-9; Pedinielli L et al.1964, Ann Chir 18:1461-74; Janssen I M et al. 1993, Br J Surg 80:875-8),and fixation of a part of the stomach to an immobile structure, e.g.,the preaortic fascia, as in the Hill repair (Hill L D 1967, Ann Surg166:681-92) or the anterior rectus sheath (as in an anteriorgastropexy). Boerma J 1969, Surgery 65:884-9. Several of theseoperations also include a crural repair of the esophageal hiatus in thediaphragm. In the 1950s, Collis popularized gastroplasty as analternative operation for gastroesophageal reflux, especially for thosepatients with a short esophagus. Collis J L 1957, J Thoracic Surg34:768-78. He created a gastric tube (neoesophagus) in continuity withthe shortened esophagus, which effectively increased the total andintra-abdominal length of the esophagus and resulted in clinicalimprovement in patients with GERD. Collis J L 1968, Am J Surg115:465-71.

With the development of minimally invasive surgical techniques,especially laparoscopic cholecystectomy in the early 1990s, a few of theopen surgical antireflux operations were developed and modified for usewith laparoscopy. The laparoscopic Nissen fundoplication is currentlythe most widely used laparoscopic antireflux operation. Jamieson G G etal. 1994, Ann Surg 220: 137-45. Other laparoscopic antirefluxoperations, for example the laparoscopic Hill repair (Kraemer S J et al.1994. Gastrointest Endosc 40:155-9), ligamentum teres cardiopexy(Nathanson L K et al. 1991, Br J Surg 78:947-51), and some modifiedoperations with partial wraps (Cuschieri A et al. 1993, Surg Endosc7:505-10; McKernan J B 1994, Surg Endosc 8:851-6) have also beenreported. These laparoscopic antireflux operations appear to producegood results with relatively short, pain-free postoperative recoverytimes in most patients. Falk G L et al. 1992, Aust N Z J Surg 62:969-72.However, laparoscopic operations themselves remain lengthy, technicallydemanding procedures requiring general anesthesia, best reserved for asmall subset of patients with severe symptoms refractory to proton pumpinhibitor or other medical treatments for GERD.

Attempts at laparoscopic transgastric antireflux surgery in animals havealso been reported. Jennings et al. developed a method of forming agastric fundoplication by creating an esophageal intussusception andplicating the gastric fundus around the esophagus using a purpose-builtstapling device. Jennings R W et al. 1992, J Laparoendosc Surg 2:207-13.There have been some attempts to treat reflux disease at flexibleendoscopy. An early endoscopic approach to control GERD was to injectcollagen in and around the LES. O'Connor and Lehman treated ten patientsby this method with some success, although some patients requiredfurther injections at the LES to maintain symptomatic relief. O'ConnorKW and Lehman G A 1988, Gastrointest Endosc 34:106-12. Donahue et al.demonstrated that GERD, induced with high-dose intravenous atropine indogs, could be controlled by injection of 5 percent morruhate sodium inthe proximal gastric region 1 to 2 cm distal to the LES at flexibleendoscopy and suggested that the proximal gastric sclerosis caused bythe injection formed an effective antireflux barrier. Donahue PE et al.1990, Gastrointest Endosc 36:253-6: Donahue P E et al. 1992, World JSurg 16:343-6. Endoscopic proximal gastric sclerosis induced by Nd:YAGlaser has also been shown to create a potential reflux barrier in dogs.McGouran R C M and Gallowav J M 1990. Gastrointest Endosc 36:531-2.Recently, Harrison et al. described a method of forming a flap valve atthe GEJ by creating an intussusception of esophagus into stomach. U.S.Pat. No. 5,403,326. LoCicero disclosed an endoscopic method for reducinggastroesophageal reflux in U.S. Pat. No. 5,887,594.

SUMMARY OF THE INVENTION

In a first aspect, the present invention relates to endoscopic methodsand instruments for reconfiguring tissue within a hollow body organ of asubject. The methods and instruments of this invention are useful forreducing flow of fluid contents from a first hollow organ into a secondhollow organ in fluid communication with the first hollow organ. Themethods and instruments of this invention permit an entirely endoluminaltechnique for reconfiguring tissue within a hollow body organ of asubject.

In the first aspect, the method includes the steps of engaging at leasta portion of the inner surface of the first hollow organ, manipulatingthe engaged portion of tissue so as to reconfigure at least a part ofthe first hollow organ from within, and permanently securing thereconfigured portion so that the reconfigured tissue retains the newconfiguration achieved by manipulation of the engaged portion.

In some embodiments of the invention, the reconfiguring can comprise aninvagination of a portion of the wall of the hollow organ. Theinvaginated portion can assume the shape of one of a number of variouspossible geometries. The new configuration of tissue is then permanentlyfixed by the application of at least one tissue fixation device.

In other embodiments of this aspect of the invention, the reconfiguringcan comprise an evagination of a portion of the wall of the holloworgan. In certain embodiments the evaginated portion can be affixed toanother portion of the same organ. In other embodiments the evaginatedportion may be fixed to another evaginated portion of the same organ.

The method may involve repetition of at least one of the engaging,reconfiguring, and securing steps.

In some embodiments the permanently secured reconfigured tissuecomprises a tissue fold. In other embodiments the permanently securedreconfigured tissue comprises a shape that may be described as a bulgeor a mound. In yet other embodiments the permanently securedreconfigured tissue can take the form of a ridge, a jellyroll, a tube, acone, or a horn.

In some embodiments the step of engaging tissue includes nonpenetratingtechniques. Nonpenetrating methods of engaging tissue include clampingand applying a suction.

In some embodiments the step of securing includes applying at least onebiocompatible tissue fixation device selected from the group consistingof a staple, a tack, a rivet, a two-part fastener, a helical fastener, asuture, and a T-bar suture. In other embodiments the step of securinginvolves application of a tissue adhesive.

According to some embodiments of this aspect of the invention, thepermanently secured reconfigured tissue is effective to reduce flow ofcontents of the first hollow organ into the second hollow organ.

In some embodiments of this aspect of the invention the method includesthe step of endoscopic visualization of at least a portion of theengaged tissue. In other embodiments of this aspect of the invention themethod includes the step of endoscopic visualization of at least aportion of at least one of the steps of engaging, reconfiguring, andsecuring.

In a second aspect the invention relates to an endoscopic method oftreating and/or preventing GERD. The method includes the steps ofengaging at least a portion of the inner surface of the stomach,manipulating the engaged portion of stomach tissue so as to reconfigureat least a part of the stomach from within, and permanently securing thereconfigured portion so that the reconfigured tissue retains the newconfiguration achieved by manipulation of the engaged portion. In apreferred embodiment of this aspect of the invention the securing doesnot involve tissue of the esophagus.

Major advantages of the invention as it relates to the treatment of GERDinclude recreation of normal anatomy, reduced morbidity, increasedefficacy, and technical ease in clinical practice. In particular, themethod reestablishes normal gastroesophageal flap valve anatomy, avoidssafety concerns related to methods which involve stapling through theesophagus, avoids possible functional compromise associated withplacement of tissue fixation devices directly in sealing surfaces, andcan be performed by an endoscopist with the subject sedated but notunder general anesthesia.

According to some embodiments of this aspect of the invention, thepermanently secured reconfigured tissue is effective to reduce flow ofcontents of the stomach into the esophagus while allowing the normalpassage of food from the esophagus into the stomach. In some embodimentsof this aspect of the invention, the permanently secured reconfiguredtissue is effective to reduce gastroesophageal reflux.

According to some embodiments of this aspect of the invention, thepermanently secured reconfigured tissue is effective to reduce symptomsrelated to gastroesophageal reflux. In certain embodiments of thisaspect of the invention, symptoms related to gastroesophageal reflux arereduced by at least 50 percent.

In some embodiments of this aspect of the invention, the permanentlysecured reconfigured tissue is effective to increase the GEJ yieldpressure. In preferred embodiments the GEJ yield pressure is increasedby an amount effective to reduce flow of contents of the stomach intothe esophagus under normal, non-vomiting situations.

In a preferred embodiment of this aspect of the invention the steps ofengaging, manipulating, and securing are performed at the time of makingan endoscopic diagnosis of GERD.

Three different methods are disclosed for treating GERD depending uponthe endoscopic evaluation. The various methods are all directed to therecreation of normal tissue geometry which favors the unidirectionalpassage of fluids and food from esophagus to stomach and restrictsreflux of stomach contents into esophagus. A first method is employed ifthere is a sufficient flap at the GEJ, but the sealing surfaces are notin apposition. In one embodiment of this method, a layer of the stomachwall is engaged at two or more independent points near the opening ofthe esophagus into the stomach on the side of the aperture at the GEJopposite the existing flap portion of the gastroesophageal flap valve.These engaged points are moved toward each other to create a tissuebulge or mound that displaces the sealing surfaces closer together.e.g., displaces the valve seat toward the flap. This bulge or mound issubsequently retained in place using a tissue fixation device. Inanother embodiment of this method, stomach tissue is engaged at twopoints near the opening of the esophagus into the stomach on the sameside of the aperture at the GEJ as the flap. This tissue is squeezedinto closer approximation to create a bulge that displaces the sealingsurfaces closer together, e.g., displaces the flap toward the valveseat. The resulting bulge or mound is fixed by at least one tissuefixation device. In yet another embodiment of this method, stomachtissue is engaged at two or more pairs of independent points, one pairof points disposed on one side of the aperture at the GEJ and the otherpair of points disposed on the contralateral side of the aperture at theGEJ. The points of each individual pair of points of tissue engagementare moved toward one another and fixed by at least one tissue fixationdevice to bring and to hold the sealing surfaces in closer and effectiveapposition.

In a method of treating GERD used where there is not a sufficient flapof tissue, either because an existing flap is too small or because thereis no flap present at all, but the sealing surfaces are in apposition, aportion of the inner aspect of stomach wall is engaged at one or morepoints on one side of the aperture at the GEJ manipulated toward theopposite side of the aperture at the GEJ to augment or recreate a flap.The augmented or recreated flap may be either rectangular or triangularor any other suitable shape. Fixation devices are employed to hold theaugmented or recreated flap over the aperture at the GEJ. Alternatively,the tissue may be invaginated and tissue fixation devices are deployedat the base of the flap to fix it prior to any further manipulation.Thereafter, the flap is manipulated to cover the GEJ.

Where there is not a sufficient flap of tissue and the sealing surfacesare not in apposition, another method is used for treating GERD. Twosites on the inner aspect of the stomach wall and adjacent to the GEJare engaged by two tissue engagement device elements. The elements aremoved in relation to the GEJ to create a pair of evaginations straddlingthe GEJ. These two evaginations are caused to come into apposition, andtissue securing devices are deployed to fix one evagination to theother. In a preferred embodiment of this method, an aspect of thediaphragm is sandwiched and fixed between the two evaginations of thestomach. This latter embodiment of this method can also be used forrepairing a hiatus hernia.

In a third aspect of the invention, instruments are provided forperforming the foregoing methods. A preferred instrument includes all ofthe necessary tools on one instrument which can be manipulatedexternally of the stomach. Preferably, the instrument is deliveredendoscopically through the mouth. The instrument includes an inner andouter tube and two stapler arms pivotally mounted to the inner tube.Disposed on the distal end of the stapler arms are a pair of smallgraspers disposed in apposition. A stapler cartridge is disposed also onthe end of one stapler arm, while an anvil is disposed on the distal endof the other stapler arm. Mounted in an articulating manner to the outertube are a pair of grasper arms which extend oppositely from the staplerarms.

Another instrument utilized for engaging and manipulating the tissueincludes a pair of toothed, interengaging rollers which can beintroduced endoscopically. A further example of a tissue engaging andmanipulating device is a suction device, such as a tube having anopening on one end or on one side and apparatus for reducing thepressure within the tube sufficient to allow the tube to engage tissueat the opening.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention will be more fully appreciated from the following detaileddescription when taken in conjunction with the accompanying drawings inwhich:

FIG. 1 is a pictorial representation of a stomach in anteroposteriorcutaway view in which a gastroscope has been advanced through the lumenof the esophagus into the lumen of the stomach and retroflexed tovisualize the GEJ;

FIG. 2 is a pictorial representation of a stomach as in FIG. 1 with atissue engaging device within the lumen of the stomach;

FIG. 3 is a pictorial representation of a stomach as in FIG. 2, wherethe tissue engaging device has engaged and invaginated a portion of thestomach wall;

FIG. 4 is a pictorial representation of a sectional view of a stomachlooking toward the opening of the esophagus into the stomach, showingtwo points of tissue engagement and arrows indicating the direction offorce to be applied to engaged tissue to create a tissue fold coveringthe GEJ;

FIG. 5 is a pictorial representation of a sectional view of a stomachlooking toward the opening of the esophagus into the stomach, showingthe invaginated rectangular tissue fold covering the GEJ;

FIG. 6 is a cross-sectional view of a stomach looking toward the openingof the esophagus into the stomach, showing an invaginated triangulartissue fold covering the GEJ;

FIG. 7 is a pictorial representation of a stomach as in FIG. 3, with anendoscopic tissue securing device also introduced into the lumen of thestomach via the esophagus;

FIG. 8 is a pictorial representation of a stomach in anteroposteriorcutaway view following deployment of one tissue fixation device tomaintain the invaginated portion of stomach wall;

FIG. 9 is a pictorial representation of a stomach depicting a row oftissue fixation devices;

FIG. 10 is a pictorial representation of a stomach depicting threeparallel rows of tissue fixation devices;

FIG. 11 is a pictorial representation of a stomach depicting nonparallelrows of tissue fixation devices;

FIG. 12 is a pictorial representation of a stomach depicting atriangular array of tissue fixation devices;

FIG. 13 is a pictorial representation of a stomach depicting multipletissue fixation devices in curved rows;

FIG. 14 is a cross-sectional view of a stomach looking toward theopening of the esophagus into the stomach, showing a normalgastroesophageal flap valve;

FIG. 15 is a cross-sectional view of a stomach looking toward theopening of the esophagus into the stomach, showing an invaginated tissuebulge opposite the flap of the gastroesophageal flap valve;

FIG. 16 is a cross-section view of a stomach looking toward the openingof the esophagus into the stomach, illustrating one method of bringingtogether sealing surfaces and the existing gastroesophageal flap valve;

FIG. 17 is a cross-sectional view of a stomach looking toward theopening of the esophagus into the stomach, showing a method ofaugmenting an existing gastroesophageal flap valve;

FIG. 18 is a cross-sectional view of a stomach looking toward theopening of the esophagus into the stomach, showing fixation of aninvaginated fold of tissue at its base with three tissue fixing devices;

FIG. 19 is a cross-sectional view of a stomach looking toward theopening of the esophagus into the stomach, showing a rectangularinvaginated fold of tissue fixed at its base covering the GEJ;

FIG. 20 is a pictorial representation of the stomach of FIG. 1 in whicha combination tissue engaging device/tissue securing device has beenadvanced into the lumen of the stomach via the lumen of the esophagus;

FIG. 21 is a pictorial representation of the stomach of FIG. 20following creation and apposition of two evaginations of stomach wall;

FIG. 22 is a pictorial representation of the stomach of FIG. 20 inexterior view showing the direction of manipulation of stomach tissuefrom within;

FIG. 23 is a pictorial representation of the stomach of FIG. 22 showingfixation between evaginations of stomach wall;

FIG. 24 is a pictorial representation of the stomach of FIG. 23 showingfixation of an aspect of the diaphragm between evaginations of stomachwall;

FIG. 25 is a side-elevation view of a preferred embodiment of a tissueengaging, manipulating and fixing device of this invention;

FIG. 26 is a side-elevation, schematic view of a portion of the deviceof FIG. 25;

FIG. 27 is a pictorial representation of a corkscrew-like tissueengagement device;

FIG. 28 is a pictorial representation of (top) an open-ended tubesuction tissue engagement device, (middle) a blind-ended tube suctiontissue engagement device, and (bottom) an open-ended and flanged tubesuction tissue engagement device;

FIG. 29 is a pictorial representation of a two-part tissue fixationdevice;

FIG. 30 is a partial side, elevation, schematic view of the device ofFIG. 25;

FIG. 31 is a side-elevation view of a preferred embodiment of a tissueengaging, manipulating and fixing device of this invention as in FIG.25, further including pressure monitoring tubes; and

FIG. 32 is a side, elevation view of the device of FIG. 25 illustratingone position of the arms thereof;

FIG. 33 is a side, elevation view of the device of FIG. 25 showing yetanother position of the arms thereof;

FIG. 34 is a side, elevation view of the device of FIG. 25 showing yetanother position of the arms thereof;

FIG. 35 is a side, elevation view of the device of FIG. 25 showinganother position of the arms thereof;

FIG. 36 is a schematic, partially cut-away side view of a stomachillustrating use of the device of FIG. 25 therein; and

FIG. 37 is a perspective view of a tissue engaging device fitted withopposing rollers.

DETAILED DESCRIPTION OF THE INVENTION

Various aspects of the invention will now be described with reference tothe figures. While this invention has particular application to reducinggastroesophageal reflux, the methods and devices of the invention arenot limited to this particular application alone, however, for they canbe applied to a stomach as well as to other hollow body organs asdiscussed below.

A. Endoscopic Methods for Reconfiguring Tissue Within a Hollow BodyOrgan.

In one aspect, the present invention provides endoscopic methods forreconfiguring tissue within a hollow body organ. This aspect of theinvention will now be described with particular reference to FIGS. 1-13which disclose the steps of the method of the invention as applied tothe stomach for purposes of illustration only. The method of theinvention may be applied to any hollow organ, as defined below. In abroad sense, the methods include at least the steps of engaging aportion of the inner surface of the hollow organ to be reconfigured,manipulating the engaged portion of tissue to create thereconfiguration, and fixing the manipulated tissue to retain thereconfiguration achieved in the manipulation. The methods may alsoinclude the step of endoscopic visualization during all or part of theprocedure. Details of the shapes that can be assumed by the reconfiguredtissue are discussed below.

As used herein, “endoscopic method” refers to a technique for performinga medical procedure on a subject in which access to the tissue to betreated is gained via an endoluminal approach. In a preferred embodimentan endoscopic method is performed without a contemporaneous invasiveapproach involving a surgical incision to gain access to the area oftreatment. This preferred embodiment embraces use of at least oneintravenous catheter for the administration of crystalloid or colloidfluids or medication to the subject, but does not require placementthrough the abdominal wall of an intraabdominal set of trocars,laparoscope, or the like.

The methods of the invention also contemplate gaining access to theinterior of a subject's stomach via a gastrotomy or gastrostomy. Suchmethods, which retain the feature of involving minimally invasive accessto tissue to be reconfigured, may be of particular valve in situationswhere access via the esophagus is not possible due to distortion ordisruption of normal oropharyngeal or proximal esophageal anatomy. Suchmethods may also be of particular value when a gastrotomy or gastrostomyis present for other medical reasons, such as for enteral feeding, forexample.

As used herein, “hollow organ” refers to an organ of a subject's bodywhich depends for its principal function upon its ability to receiveand/or act as a conduit for liquid contents. A hollow organ typically isin fluid communication with another hollow organ and/or with the outsideof the body. Many organs of the gastrointestinal and genitourinarytracts are classified as hollow viscus organs. These include stomach,gall bladder, uterus, and bladder. Other hollow organs which act more asfluid passageways include esophagus, small and large intestines, hepaticducts, cystic duct, common bile duct, pancreatic duct, heart, veins,arteries, vagina, uterine (i.e., Fallopian) tubes, ureters, and urethra.

In the case of a stomach being the hollow organ. “liquid contents”includes any of the following: masticated food, imbibed liquid, chyme,gastric mucus, gastric acid, and other gastric secretions. In othercontexts “liquid contents” can also include other body fluids such asintestinal contents, bile, exocrine pancreatic secretions, blood, andurine.

Endoscopic visualization. Endoscopic visualization can be used for all,at least a part, or none of the procedure. In certain preferredembodiments of the invention, the method is performed in conjunctionwith endoscopic visualization of at least the engaged portion of tissue.Typically, as shown in FIG. 1, a first step in the method of theinvention includes advancing an endoscope 14 into the interior or lumen13 of a first hollow organ 10. Preferably, but not necessarily,endoscope 14 is advanced into the interior of first hollow organ 10 byway of a lumen 11 of a second hollow organ 12 in fluid communicationwith the first hollow organ 10.

Endoscopes are well known in the art. Viewing endoscopic instrumentstypically are equipped with a lighting element and a viewing elementenabling an operator to view the interior of the accessed body cavity.Viewing endoscopic instruments often also include at least one fluidchannel suitable for introducing and/or withdrawing a fluid, gas, ormedicament, and a working channel suitable to accommodate a remotelyoperated surgical tool such as a needle, a grasper, a biopsy device, abrush, an electrocautery electrode, and the like. Acceptable viewingelements include fiberoptic-assisted direct visualization, televisionarray, and video array endoscopes. Endoscope 14 can be introduced intolumen 13 of the first hollow organ for at least one aspect of theprocedure and removed for at least one other aspect of the procedure.Accordingly, a viewing endoscope 14 can be introduced, removed, andreintroduced for any one or for any combination of steps of the methodof the invention.

For the purposes of the invention, a viewing endoscope can be aninstrument separate from any other instrument employed in the practiceof the method of the invention. Alternatively, a viewing endoscope canwork cooperatively with at least one other instrument used in thepractice of the invention by, for example, the at least one otherinstrument's cooperatively positioning the endoscope. In otherembodiments, a viewing endoscope can be incorporated into a tissueengaging device, at least a portion of a tissue fixing device, or partof a combined tissue engaging and tissue securing device.

It should be noted that existing flexible endoscopes may not besufficiently rigid when flexed to serve as the working platform forperforming the types of stomach tissue manipulation described below. Thetypes of pushing, pulling, and side-to-side manipulations to beperformed in the vicinity of the opening of the esophagus into thestomach require a degree of mechanical leverage for which a retroflexedgastroscope normally cannot serve as an adequate fulcrum. To performthese manipulations in a stomach, an endoscope may be used, for viewingpurposes, in conjunction with a specially structured instrument such asdescribed below. In applications where rigid endoscopes may be used, themethods may be practiced without such specially structured instruments.

In other embodiments of the invention, the method is performed at leastin part with non-endoscopic visualization of the tissue engaged.Non-endoscopic methods of visualization include techniques well known inthe art, such as, without limitation, fluoroscopy, either with orwithout the use of a suitable radiographic contrast agent, andultrasound. In some embodiments the procedure can be performed withoutany endoscopic visualization.

Engaging. An early step of this aspect of the invention is engaging theselected portion of an inner surface 16 of first hollow organ 10, asshown in FIG. 2.

As used herein, the term “engaging” refers to an act of reversiblypenetrating, gripping, tweezing, holding, pressing, clamping, sucking,or otherwise contacting a tissue in a mechanical fashion so as toestablish a physical connection with the tissue. In certain preferredembodiments of the invention the engagement of tissue occurs reversiblyand essentially atraumatically.

For purposes of this invention, an endoscopic tissue engaging device isunderstood to have a proximal end and a distal end interconnected by anelongate portion of suitable length and rigidity to permit an operator,in contact with and control of the proximal end, to gain remote accessto the interior of a body cavity with the distal end of the endoscopictissue engaging device. Furthermore, the operator of an endoscopictissue engaging device is understood to be able to actuate a tissueengaging element disposed at the distal end by manipulation of at leastone aspect of a controlling mechanism disposed at the proximal end andoperatively connected to the tissue engaging element disposed at thedistal end.

The tissue engaging device in some embodiments can be a separateinstrument unto itself. In other embodiments the tissue engaging devicecan be used in combination with another endoscopic instrument. In yetother embodiments the tissue engaging device can be an element of acombination endoscopic instrument. In a preferred embodiment the tissueengaging device is an element of an endoscopic instrument which alsoincorporates a tissue securing device (see below).

As used herein, an “engaged portion” shall refer to a segment of tissueactually engaged by a device used to engage the tissue.

In certain preferred embodiments the engaged portion involves just theinner lining of the first hollow organ 10. For example the engagedportion can involve only the mucosa in a stomach. In other embodimentsthe engaged portion can involve the inner lining and at least oneadditional tissue layer of first hollow organ 10. Again with referenceto the stomach, the reconfigured portion can involve the mucosa and atleast one layer of muscular wall, up to and including the full thicknessof the stomach wall.

In certain preferred embodiments the tissue engaging device can engagetissue in a reversible and essentially atraumatic manner. Engagement oftissue in such embodiments is effective for performing subsequent stepsof the method but also allows release of engaged tissue in a mannerwhich causes little or no disruption of tissue integrity.

For example, in a most preferred embodiment the tissue engagement deviceincludes a novel corkscrew-type element, described below. Even thoughthe sharpened end of the spiral corkscrew-type element pierces in orderto engage tissue, when the spiral is removed by unscrewing it fromtissue, it leaves a single discrete point of penetration whichself-seals in the extremely pliable tissue lining of the stomach, muchas does a hole made in the same tissue with a hypodermic needle.

In yet other embodiments the tissue engaging device can be a knownclamping device. Examples of suitable endoscopic clamping devices arewell known in the art, including, without limitation, endoscopicalligator grasping forceps (see FIG. 2), forked jaw grasping forceps,rat tooth grasping forceps, three-prong grasping forceps, tripodgrasping forceps, fenestrated cup forceps, and ellipsoid fenestratedforceps. As used herein, each such endoscopic clamping device isconsidered to engage a single portion of tissue, i.e., all tissuecontacted by the various jaws of a single clamping device is consideredas a single point of tissue engagement.

In other preferred embodiments the tissue engaging device can be a novelsuction device, as described below. Tissue is engaged when contactedwith suction and released atraumatically when the suction is broken at apoint other than the point of tissue engagement.

According to the above embodiments, the tissue engaging device canengage tissue for the purposes of side-to-side manipulation, twisting,pushing, or retracting tissue. In yet another embodiment a tissueengaging device may be the sharpened end of, for example, at least oneleg of a surgical staple. According to this embodiment, the tissueengaging device can engage tissue for the purposes of side-to-sidemanipulation, twisting, or pushing, but not for retracting tissue.

In a preferred embodiment a tissue engaging device may be incorporatedinto a tissue manipulating device. In this embodiment, the elongateportion of the tissue engaging device is further structured to permitmanipulation of tissue engaged by atraumatic grasping, suction, orpiercing as above. In a most preferred embodiment, as discussed below, anovel single instrument incorporating both a tissue engaging and tissuemanipulation device is structured to permit independent engagement oftissue at two or more points, and to permit manipulation of at least twopoints of tissue with respect to each other in any direction inthree-dimensional space. The two or more independent points of tissueengagement typically are separated by at least 1 cm prior to tissueengagement.

In a preferred embodiment, an endoscopic tissue engaging device 18 isadvanced into lumen 13 of first hollow organ 10, preferably via a lumen11 of second hollow organ 12. In FIG. 2 first hollow organ 10 is shownas a stomach and second hollow organ 12 is shown as an esophagus influid communication with organ 10. Distal end 17 of endoscope 14 and adistal end of tissue engaging device 18 are shown in position in FIG. 2after they have been advanced into lumen 13 of organ 10 via the lumen 11of organ 12. The related portion of inner surface 16 of first holloworgan 10 is engaged with endoscopic tissue engaging device 18, which isdescribed below.

In one preferred embodiment engaging is accomplished by gripping tissuewith a known jawed forceps device 18 as illustrated schematically inFIG. 2. Device 18 includes opposed jaws 15 and 19 having teeth 23 or thelike. The engaging force must be sufficient to maintain physicalconnection with the engaged portion of tissue when a tissue-deformingtorque, push, or retraction is applied to the engaged tissue via thetissue engaging device, while at the same time the force distribution issufficient to avoid piercing, tearing, or cutting the surface of theengaged portion.

In certain preferred embodiments of the invention the engagementinvolves simultaneous engagement of at least two distinct sites. Thiseffect can be achieved by simultaneously applying at least two tissueengagement devices, e.g., two separate endoscopic forceps clamps, orapplying a single tissue engagement device designed to engage tissuesimultaneously at distinct sites. A device of the latter type isdescribed below.

Release of the engaged portion is necessary in order to remove theengaging device from the hollow organ of the subject after havingengaged the tissue. The engaged portion typically will participate inthe reconfigured portion; i.e., the reconfigured tissue will typicallycomprise in some aspect, be it at a basal, apical, or intermediateposition relative to the reconfigured portion as a whole, the tissueactually engaged by the engaging device in the course of reconfiguring.

Manipulating. In a subsequent step of the invention, the engaged portionof inner surface 16 of first hollow organ 10 is manipulated toreconfigure at least a portion of first hollow organ 10, as shown inFIG. 3. Inner surface 16 of first organ 10 is manipulated by device 18to create a reconfigured portion 20. In the manipulating step a physicalforce IS applied by device 18 to the engaged portion of tissue of innersurface 16 effective for pushing, pulling, twisting, rolling, folding,gathering, or otherwise displacing tissue from its original positionand/or configuration prior to application of such force. In preferredembodiments, tissue in adjacent continuity with the portion actuallyengaged will undergo at least some degree of physical deformation fromits original conformation in proportion to the magnitude and directionof force applied to the engaged portion. Manipulation of engaged tissuemay be used to create an invagination, an evagination, or a combinationof invagination and evagination of at least inner layer 16 of firsthollow organ 10.

In one embodiment of this aspect of the invention, manipulation of theengaged portion of inner surface 16 of first hollow organ 10 is achievedby applying traction force or torquing force to create reconfiguredportion 20, which is an invagination. Traction force can be linear, suchas achieved by pulling. Alternatively, traction force can be nonlinear,such as can be achieved by winding engaging tissue onto a spool.

As used herein, “invaginated portion” or “invagination” refers to aregion of tissue displaced toward the interior cavity of the holloworgan as a combined result of engaging and manipulating. The particularshape assumed by the invaginated portion will depend on factorsincluding the geometry of the engaged portion, the anatomy of theengaged organ, the plasticity of the segment of the organ engaged, andthe direction and magnitude of the force applied.

Examples of forming invaginations that assume the shape of a flap orfold are shown in FIGS. 4-6. FIG. 4 depicts a cross-sectional view of astomach looking toward the opening of the esophagus into the stomach 36.Also shown in FIG. 4 is the opening of the duodenum into the stomach 31.In FIG. 4, inner surface 16 of stomach 10 is engaged at two points 37and 39 on one side of opening of the esophagus into the stomach 36,flanking opening of the esophagus into the stomach 36. The engagedtissue is then manipulated in the direction indicated by the arrows 38,i.e., in a direction generally toward and across the opening of theesophagus into the stomach 36 from points of engagement 37 and 39. FIG.5 depicts a generally rectangular flap 40 created by the engaging andmanipulating steps shown in FIG. 4. The flap 40 is fixed at points 35,which are in the direction of or across the aperture of opening of theesophagus into the stomach 36 relative to points of engagement 37 and39. The opening of the esophagus into the stomach 36 is at leastpartially covered by rectangular flap 40. Two tissue fixation deviceseach pass through at least two layers of stomach wall: the layer orlayers forming fold 40 and at least the lining 16 of the stomach wallnear the opening of the esophagus into the stomach 36. The size andtightness of the fold depend on the location of points of fixation 35relative to the points of engagement 37 and 39 and the position of theopening of the esophagus into the stomach 36.

A method of making an alternative flap configuration is depicted in FIG.6. Inner surface 16 of stomach 10 is engaged at a single point 41 nearopening of the esophagus into the stomach 36. The engaged tissue is thenmanipulated in the direction indicated by the arrow 48, i.e., in adirection generally toward and across the opening of the esophagus intothe stomach 36 from point of tissue engagement 41. FIG. 6 depicts atriangular flap 50 created by the engaging and manipulating steps shownin FIG. 6. The opening of the esophagus into the stomach 36 is at leastpartially covered by flap 50. The fold 50 is fixed at a single point 51generally across the opening of the esophagus into the stomach 36 frompoint of tissue engagement 41. A single tissue fixation device passesthrough at least two layers of stomach wall: the layer or layers formingthe fold 50 and the lining 16 of the stomach wall near the opening ofthe esophagus into the stomach 36. The size and tightness of the fold 50depend on the location of the point of fixation 51 relative to the pointof engagement 41 and the position of the opening of the esophagus intothe stomach 36.

It is emphasized that the rectangular and triangular shapes describedabove are highly schematic. Due to the plasticity of the tissueinvolved, the actual configuration of tissue achieved by such methodsmay not appear so definitively rectangular or triangular. Nevertheless,it is useful to think in terms of these shapes or structures for thepurposes of conceptualizing the methods used to achieve the desiredfunctional effects, i.e., the inhibition of reflux.

Reconfigured portion 20 can assume any of a range of alternative shapes,including without limitation, a flap, a fold, a bulge, a mound, a ridge,a roll (“jellyroll”), a tube, a papilla, or a cone. The mechanics ofmobility of the shaped tissue depend on factors including, for example,the size, shape, thickness, radius, position, and composition of theinvolved tissue, as well as the shape of the fastener or fasteners, andthe placement position of the fastener or fasteners.

In certain embodiments, the invagination forming reconfigured portion 20can tale the shape of a tissue bulge. As used herein, “tissue bulge”refers to a gathered up or heaped up mound of tissue with a base and anapex relative to the contour of tissue from which it arises. Thecircumference at its base can be irregular or it can be substantiallyregular, e.g., substantially elliptical, substantially circular,substantially triangular, or substantially rectangular. A tissue bulgeresembles, when viewed from within the hollow organ, a lump or a mass ora papilla. A mound of tissue forming a tissue bulge is to bedistinguished from a flap or fold of tissue in that it need not havedistinct opposing surfaces or sides. As viewed from within the holloworgan, a tissue bulge can be smooth, dimpled, or furrowed.

According to an embodiment of this aspect of the invention, manipulationcan entail bringing into apposition at least two points of tissue whichare independently engaged by at least one tissue engaging device.

According to yet another embodiment of this aspect of the invention,combinations of tissue invaginations are created. Thus for example aflap and a bulge can be created in combination. Other embodimentsinclude, without limitation, at least two flaps; at least two bulges; atleast two rolls; a roll and a bulge; etc. Combinations of tissueinvaginations can be created essentially contemporaneously orconsecutively.

According to yet another embodiment of this aspect of the invention,manipulation of the engaged portion of inner surface 16 of first holloworgan 10 can be achieved by applying a leading or pushing force so as tocreate, from within, an outward protrusion of the first hollow organ(not shown). According to this method reconfigured portion 20 is anevagination rather than an invagination. An evaginated portion canassume any of a number of shapes as viewed from the exterior of thehollow organ, including, without limitation, a bulge, a lump, a ridge, aflap, a fold, a tube, a horn, and a cone. As also viewed from theexterior of the hollow organ, a tissue evagination can be smooth,dimpled, or furrowed. The circumference at its base can be irregular orit can be substantially regular, e.g., substantially elliptical,substantially circular, substantially triangular, or substantiallyrectangular. The method also contemplates the formation of a pluralityof evaginations, which may be created either simultaneously orsequentially. At least one evagination can be combined with at least oneinvagination.

In some embodiments reconfigured portion 20 involves just the innerlining of the first hollow organ 10. For example reconfigured portion 20can involve only the mucosa in a stomach. In other embodimentsreconfigured portion 20 can involve the inner lining and at least oneadditional tissue layer of first hollow organ 10. Again with referenceto the stomach, the reconfigured portion can involve the mucosa and atleast one layer of muscular wall, up to and including the full thicknessof the stomach wall.

Securing. After the manipulating step, a subsequent step involvespermanently securing reconfigured portion 20 of first hollow organ 10 toeffect a substantially permanent retention of the shape of reconfiguredportion 20, as shown in FIGS. 7 and 8. While reconfigured portion 20 oforgan 10 is maintained under control of the operator through themanipulating force applied to the engaged portion of tissue via thetissue engaging device 18, the operator causes a distal effector end 21of a tissue securing device 22 (described below) to come into contactwith reconfigured portion 20. Distal effector end 21 of tissue securingdevice 22 includes at least one biocompatible tissue fixation device 24(described below) and is structured for application of at least onebiocompatible tissue fixation device 24 into reconfigured portion 20.Tissue securing device 22 is advanced into lumen 13 of first holloworgan 10 before, along with, or after the tissue engaging device 18;thereafter, tissue securing device 22 is actuated to apply at least onebiocompatible tissue fixation device 24 to permanently secure or fix theshape of reconfigured portion 20.

As used herein, “permanently secure” refers to directed placement of atleast one biocompatible tissue fixation device effective for stabilizingtissue in a desired position. Permanently securing is preferablyaccomplished from within lumen 13 of first hollow organ 10.“Permanently” means for as long as there is clinical utility. Thisdefinition contemplates the intentional, active removal of a tissuefixation device by a practitioner based on his professional judgment.When permanently securing is accomplished by applying at least oneresorbable tissue fixation device, the invention contemplates theformation of tissue adhesion arising at the site of or as a result ofthe presence of the applied resorbable tissue fixation device during thetime such device remains intact. “Permanently securing” contemplatesthat such tissue adhesion is effective to maintain the configuration ofthe reconfigured tissue after resorption of the resorbable tissuefixation device.

According to a preferred embodiment of the invention, securing aninvaginated portion of a hollow body organ in a new position preferablydoes not involve tissue extrinsic to the first hollow body organ. Thusthe method of this invention preferably does not involve securing tissueof the first hollow body organ 10 to tissue of a second hollow bodyorgan 12 in fluid communication with the first. In the particularinstance where the first hollow body organ 10 is a stomach and thesecond hollow organ 12 is an esophagus, according to this embodiment,stomach tissue is secured only to stomach tissue, and not to tissue ofthe esophagus.

The tissue fixation device 24 of this invention is a mechanical entityuseful for stabilizing a particular configuration of at least onetissue. A tissue fixation device 24 is deployed or applied to a tissueby a tissue securing means 22 structured to deliver the tissue fixationdevice 24.

For purposes of the invention, tissue securing device 22 is understoodto have a proximal end and a distal end 21 interconnected by an elongateportion of suitable length to permit an operator, in contact with andcontrol of the proximal end, to gain remote access to the interior of abody cavity with the distal end 21 of the endoscopic tissue engagingdevice 22. Furthermore, the operator of an endoscopic tissue engagingdevice 22 is understood to be able to actuate an effector elementdisposed at the distal end 21 by manipulation of at least one aspect ofa controlling mechanism disposed at the proximal end and operativelyconnected to the effector element disposed at the distal end 21. Theeffector element can be structured to deliver at least one tissuefixation device 24, tissue adhesive, or radio frequency (RF) energy intotissue contacted with the effector element.

The tissue securing device in some embodiments can be a separateinstrument unto itself. In other embodiments the tissue securing devicecan be used in combination with another endoscopic instrument. In yetother embodiments the tissue securing device can be an element of acombination endoscopic instrument. In a preferred embodiment, the tissuesecuring device is an element of an endoscopic tissue shaping instrumentwhich also incorporates a tissue engaging device.

In a preferred embodiment tissue fixation device 24 is a biocompatiblestaple and tissue securing device 22 is an endoscopic surgical stapler.Examples of surgical staplers are well known in the art, including thosedisclosed in U.S. Pat. Nos. 5,040,715 and 5,376,095. Stapling devicescan be anviled or one-sided. A biocompatible staple is commonly made ofnon-resorbable material such as titanium or stainless steel, but othermaterials, including resorbable materials, are embraced by theinvention. In other embodiments of the invention tissue fixation device24 can be a biocompatible clip, tack, rivet, two-part fastener, helicalfastener, T-bar suture, suture, or the like, examples of which are wellknown in the art. In preferred embodiments tissue fixation device 24 isnon-resorbable.

In certain embodiments, tissue fixation device 24 penetrates only aninternal layer of first hollow organ 10. The internal layer can be, forexample, the mucosa lining the interior of the stomach. Alternatively,tissue fixation device 24 penetrates both internal and at least oneadditional layer of first hollow organ 10. The at least one additionallayer can be, for example, a muscle layer of the stomach wall. Thecombined inner layer and at least one additional layer constitute eithera partial-thickness layer or a full-thickness layer. The securing stepof this method includes, for example, fixation of an inner layer to apartial-thickness layer. This step also includes, for example, fixationof an inner layer to a full-thickness layer. In certain other methods,in the securing step, the tissue fixation device penetrates (1) apartial-thickness layer and (2) a full-thickness layer, or twofull-thickness layers of the first hollow organ 10. This latter securingstep fixes, for example, a full-thickness invagination in which two ormore distinct regions of the exterior surface of the first hollow organare brought into apposition (not shown).

In yet other securing steps where more than one tissue fixation device24 is used, there can be any combination of tissue fixation devices 24penetrating any combination of layers. For example a first tissuefixation device 24 penetrating a partial-thickness layer can be used incombination with a second tissue fixation device penetrating an innerlayer alone. As another example, a first tissue fixation device 24penetrating both an inner layer and a partial-thickness layer can beused in combination with a second tissue fixation device 24 penetratingan inner layer and a full-thickness layer. These and other possiblecombinations of tissue fixation devices used to fix combinations oftissue layers are intended to be encompassed by the invention.

FIGS. 9-13 illustrate various geometric patterns that can be used whenthe at least one tissue fixation device 24 is a biocompatible staple.When more than one tissue fixation device 24 is deployed, the tissuefixation devices 24 can be delivered sequentially or simultaneously.Examples of geometric patterns include a line (FIG. 9); two or moreparallel lines (FIG. 10); two or more nonparallel lines, including a “T”(FIG. 11) and a cross; at least one polygon, including a triangle (FIG.12); at least one arc, including two or more curves (FIG. 13); at leastone circle. The purposes of alternate configurations are to spread thestresses due to fixation over a greater area of tissue; provide afail-safe situation, i.e., maintain fixation even if one of the tissuefixation devices should fail; create and maintain tissue shape andpositioning for optimal clinical effect; and encourage healing, bycreating multiple holes in tissue, causing bleeding or fibrocytemigration.

Achievement of the desired reconfiguring of tissue can require two ormore cycles of engaging, manipulating, and securing. For example, in aparticular instance the desired size or shape to be effected might notbe fully achieved in a single cycle of engaging, manipulating, andsecuring. The method also contemplates releasing the engaged portion ofthe first hollow organ 10 and optionally re-engaging that portion orengaging another portion and then manipulating and permanently securingthe portion thus engaged.

The shape of tissue assumed by the secured, reconfigured portion 20 maybe effective to restrict flow of liquid contents of the first holloworgan 10 into the second hollow organ 12, while allowing normal flowantegrade from the second hollow organ 12 into the first hollow organ10. Examples of undesired flow from one hollow organ into a contiguoussecond hollow organ include gastroesophageal reflux, reflux of urinefrom the urinary bladder retrograde into a ureter, regurgitant bloodflow from one chamber to another within the heart, and blood flowthrough an atrial or ventricular septal defect.

The permanently secured reconfigured portion 20 preferably is effectiveto restrict reflux of contents of the first hollow organ 10 into thesecond hollow organ 12. Reconfigured portions may be a valve thathinders or restricts passage of contents from organ 10 to organ 12.Preferably the valve operates as a one-way valve. In a preferredembodiment of the invention the valve created to accomplish theobjectives is a flap valve. Examples of such valves occurring naturallyin humans include aortic, mitral, pulmonary, and tricuspid valves of theheart, the gastroesophageal flap valve, the ileocecal valve, theepiglottis, and valves in veins. Flap valves are also normally found atthe junction between the urinary bladder and the ureters. Other types ofvalves which could be created according to the method of this inventioninclude nipple valves and multi-leafed valves.

In the case of the stomach it is most desirable that any valveinterconnecting the stomach and the esophagus function effectively torestrict the flow of gastric contents into the esophagus under normalcircumstances. The ideal valve should function in such a manner so as topermit, under appropriate circumstances, release of gas from the stomachinto the esophagus, regurgitation of stomach contents into theesophagus, and interventional aspiration of stomach contents. In thenormal individual the gastroesophageal flap valve achieves this desireddegree of functional discrimination.

The desired effect of the resulting secured, reconfigured portion 20includes at least one of the following: reduction in the frequency ofunwanted backflow; reduction in the volume of unwanted backflow orreflux; reduction of symptoms related to unwanted backflow or reflux;and increasing yield pressure between the first hollow organ 10 and thesecond hollow organ 12. Any such desired effect is measured relative toreflux under similar circumstances, e.g., in relation to recumbency,inversion, coughing, sneezing, etc., before the combined steps ofreconfiguring and securing. Any such effect is achieved by the abilityof the secured, reconfigured portion 20 to impede flow of liquid acrossa junction from the first hollow organ 10 into the second hollow organ12, such as the GEJ proximal to opening of the esophagus into thestomach 36.

In a preferred embodiment the secured, reconfigured portion 20 reducesthe frequency of episodes of unwanted backflow by at least 50 percent.Most preferably the frequency of unwanted backflow episodes is reducedby about 100 percent.

In another preferred embodiment the secured, reconfigured portion 20reduces the volume of unwanted fluid backflow by at least 20 percent. Ina more preferred embodiment the volume of unwanted fluid backflow isreduced by at least 50 percent.

In another preferred embodiment the secured, reconfigured portion 20 iseffective for increasing the competence of the GEJ. As used herein,“competence of the GEJ” refers to the ability of the GEJ to limit theflow of contents of the stomach into the esophagus while allowing thenormal passage of food from the esophagus to the stomach. A fullycompetent GEJ would completely limit the flow of contents of the stomachinto the esophagus while allowing the normal passage of food from theesophagus to the stomach.

As used herein, the words “symptoms of reflux” refer to subjectiveexperiences of a subject as well as objective clinical signsattributable to backflow of contents of a distal hollow organ into thelumen of a proximal hollow organ in fluid communication with the first.In a preferred embodiment the symptoms of reflux are related togastroesophageal reflux.

As used herein, “effective to reduce symptoms of reflux” refers tosubstantially reducing the frequency, number, and/or severity ofsymptoms arising as a result of episodic or chronic reflux. In apreferred embodiment the frequency of symptoms of reflux is reduced byat least 50 percent. In another preferred embodiment the severity ofsymptoms of reflux is reduced by at least 50 percent. In yet anotherembodiment the number of symptoms of reflux is reduced by at least one.

The secured, reconfigured portion 20 also may be effective forincreasing the yield pressure of the junction connecting first holloworgan 10 to second hollow organ 12, such as the GEJ proximal to theopening of the esophagus into the stomach 36. As used herein, the term“yield pressure” refers to the intraluminal pressure of first holloworgan 10 which overcomes a pressure gradient otherwise maintainedbetween first hollow organ 10 and second hollow organ 12. In otherwords, the yield pressure is the change in pressure which is sufficientto cause flow of contents of first hollow organ 10 into the lumen 11 ofthe second hollow organ 12. As applied to the yield pressure of the GEJ,yield pressure is the maximum pressure reached inside the stomach priorto refluxive flow when it is infused with gas or liquid, minus thepressure at rest in the stomach. Normal yield pressures of the GEJ fallwithin the range of 7-15 mm Hg in healthy human subjects (McGouran RCMet al. 1988, Gut 29:275-8; Ismail T et al. 1995, Br J Surg 82:943-7), ≦5mm Hg in subjects with GERD (McGouran RCM et al. 1988, supra; McGouranRCM et al. 1989, Gut 30:1309-12; Ismail T et al. 1995, supra), and >14mm Hg in subjects with GERD following successful reflux surgery(McGouran RCM et al. 1989, supra; Ismail T. et al. 1995, supra).

As used herein, “effective to increase yield pressure” refers to anobjectively measurable increase in the yield pressure over thepretreatment yield pressure. In a preferred embodiment of the invention,the yield pressure is increased to at least 75 percent of normal.Practice of the invention can include but does not require objectivemeasurement of an increase in yield pressure.

Bench testing was conducted using an excised pig stomach and attachedesophagus to demonstrate the principle of creating a bulge to preventgastroesophageal reflux. The duodenum was clamped, an incision was madein the greater curvature of the stomach, and the stomach was invertedand filled with water. Water was observed to flow under the force ofgravity from the stomach to the esophagus in a steady stream. A bulgewas made in the wall of the stomach within one inch of the opening ofthe esophagus into the stomach. The bulge was fixed in place with astaple. The stomach was then refilled with water. No water was observedto flow under the force of gravity from the stomach to the esophagusfollowing this procedure. A one-half inch diameter cylinder was passedthrough the esophagus and opening of the esophagus into the stomach bothbefore and after creation of the bulge, indicating that the bulge didnot close the lumen of the opening of the esophagus into the stomach.

To demonstrate the in vivo effect of creating a bulge on yield pressureof a stomach, a pig was placed under general anesthesia and surgicalaccess to the stomach was gained via an abdominal incision. Two smallpunctures were made in the stomach, through which a tube for salineinflow was placed into one, and a pressure-monitoring catheter wasplaced into the other. Purse-string sutures were placed around eachincision to secure the tubes and seal the stomach tissue to preventleakage. After clamping the pylorus, saline was infused into the stomachthrough the inflow tube until the stomach was full. The stomach was thensqueezed by hand and the maximum pressure obtained was observed onequipment attached to the pressure monitoring catheter. Average maximumyield pressure obtained was 32 mm Hg.

The stomach was drained and an incision was made in the wall of thestomach to provide access for instrumentation into the stomach. A bulgewas created within one inch of the opening of the esophagus into thestomach and fixed in position with a staple. The incision was closedwith suture and the stomach refilled with saline. The stomach was thensqueezed again by hand and the maximum pressure obtained observed asbefore. Average maximum yield pressure obtained after creation of thebulge was 57 mm Hg. Yield pressure thus increased nearly 80 percent overbaseline.

B. Endoscopic Methods for Reconfiguring Tissue Within a Stomach to TreatGERD.

In another aspect, the invention relates to endoscopic methods forreconfiguring tissue within a stomach to treat GERD. The methods arebased upon the observation that a flap of stomach tissue covers theaperture of the esophagus as it enters the stomach, forming a flap valvewhich provides an effective barrier to reflux of liquid contents of thestomach. An effective flap valve functions as a one-way valve allowingfree passage of swallowed liquids and solids from the esophagus into thestomach, but not vice versa, while permitting appropriate escape of gasfrom the stomach into the esophagus, e.g., during belching.

As used herein, a “flap valve” has an aperture and at least two sealingsurfaces which, when properly apposed, effectively close the aperture.In a preferred embodiment, at least one of the sealing surfaces isprovided by a mobile flap or ridge of tissue. In its closed position,the sealing surface of the flap contacts at least one other sealingsurface, including either another flap or a valve seat, in such a manneras to form an effective closure or seal around the aperture.

In certain preferred embodiments a competent flap valve can function asa one-way valve, favoring flow past the valve in one direction andlimiting flow past the valve in the opposite direction. As applied to astomach, a competent flap valve should favor free flow of swallowedmaterials from esophagus 12 into stomach 10 and limit free flow ofliquid contents from stomach 10 into esophagus 12. In a normal subjectsuch a flap valve opens to permit a swallowed bolus to pass fromesophagus 12 into stomach 10, but the flap valve otherwise normallyremains closed, preventing reflux of liquid contents from stomach 10into esophagus 12.

FIG. 14 depicts the configuration of a normal gastroesophageal flapvalve 70 in a stomach 10 having an inner surface 16. Here flap portion67 and valve seat 69 furnish the requisite sealing surfaces. In thisview taken from the perspective of the interior of the stomach lookingtoward the opening of the esophagus into the stomach 36, the flapportion 67 of valve 70 is to the right, covering opening of theesophagus into the stomach 36, and the seat 69 of the valve is to theleft of and beneath the covering flap. As used herein in reference to astomach 10, a flap valve 70 shall be considered to “cover” the openingof the esophagus into the stomach 36 even though flap valve 70, beingwithin the stomach 10, is caudal or inferior to the opening of theesophagus into the stomach 36.

Two factors may make a flap valve 70 incompetent. One factor is theabsence of a sufficient flap of tissue 67. The opening of the esophagusinto the stomach 36 cannot be effectively closed if a sufficient flapportion 67 is not present to form a seal against at least one othersealing surface 69. The flap 67 can be either be too small or simplyabsent altogether. The second factor is the effective apposition ofsealing surfaces. The opening of the esophagus into the stomach 36cannot be effectively closed, even if a sufficient flap portion 67 ispresent, if the sealing surfaces cannot be properly apposed. As usedherein, sealing surfaces are properly “apposed” when their mutualcontact causes the surfaces to form an effective barrier to reflux.

In clinical application, the existence or appearance of agastroesophageal flap valve and the apposition of sealing surfaces aretypically evaluated by endoscopic visualization in which the examiningendoscope is retroflexed to view the opening of the esophagus into thestomach. The shaft of the endoscope proximal to the retroflexed segmenttraverses the opening and thus the valve and sealing surfaces are viewedin the context of their contact with the shaft of the endoscope. By wayof example, Hill and colleagues developed the following grading systemto describe the appearance of the flap valve as thus viewed: Grade I, inwhich there is a prominent fold of tissue extending along the shaft ofthe endoscope and closely apposed to the endoscope through all phases ofrespiration; Grade II, in which the fold is less prominent andoccasionally opening and closing around the endoscope duringrespiration; Grade III, in which a fold is present but is neitherprominent nor in close contact with the endoscope; and Grade IV, inwhich there is no fold present and the opening is agape about theendoscope. Hill LD et al. 1996, Gastrointest Endosc 33:541-7. Followingthe conventions provided by this general scheme, it is evident thatsealing surfaces can be classified as apposed in Grade I. Not evidentunder this scheme, but nonetheless possible, sealing surfaces can beapposed in any situation, regardless of the presence or absence of anyfold of tissue, provided there is continuous contact between the entirecircumference of the endoscope shaft and tissue at the junction betweenthe esophagus and the stomach.

The three methods described below are based upon the endoscopicappearance of the gastroesophageal flap valve (Table 1). A first methodis directed to the clinical situation where there is a sufficient flappresent but the sealing surfaces are not apposed. The method involvesbringing the sealing surface and the flap closer together to tighten anexisting flap valve. A second method is directed to the clinicalsituation where there is not a sufficient flap present but the sealingsurfaces are apposed. The method involves the creation of a flap whenthere is none present, and alternatively, augmentation of an existingflap that is simply not large enough to cover the opening of theesophagus into the stomach. A third method is directed to the clinicalsituation where there is neither a sufficient flap present norapposition of sealing surfaces. The method involves creating oraugmenting a flap and bringing the flap or sealing surfaces closertogether. TABLE 1 Selection Criteria for Treating GERD Based uponEndoscopic Evaluation ENDOSCOPIC EVALUATION Is a sufficient Are the flapof sealing surfaces TREATMENT tissue present? apposed? FIG. numberRationale Yes Yes 14 No treatment required Yes No 15, 16, 17 Bringssealing surfaces closer together to tighten existing flap valve No Yes4, 5, 6, Creates or augments 18, 19 flap No No 20, 21, 22, Creates oraugments 23, 24 flap and brings sealing surfaces closer togetherIn preferred embodiments of the invention, the three methods areperformed at least in part with endoscopic visualization of stomachtissue for at least a part of one or more steps of the procedure. Apreferred instrument for practicing the methods is disclosed in aseparate section below. Other aspects of each of the three methods willnow be discussed in more detail.

Sufficient Flap Present but Sealing Surfaces Inadequately Apposed:Creation of a Bulge or Tightening of Existing Flap Valve.

To remedy the problem where there is a sufficient flap present but thesealing surfaces are inadequately apposed, as shown in FIGS. 14 and 15,inner surface 16 of stomach 10, optionally including at least oneunderlying layer of stomach wall 34, is engaged at two or moreindependent points 73 and 75. Points of engagement 73 and 75 aredisposed near the opening of the esophagus into the stomach 36, and onthe side of the opening of the esophagus into the stomach 36 oppositethe existing flap portion 67 of gastroesophageal flap valve 70. Thepositions of points of engagement 73 and 75 as shown in FIG. 15 are notmeant to be limiting. As shown in FIG. 15, the positions of the pointsof engagement 73 and 75 and of the flap portion 67 are related by theirdisposition on opposite sides of the opening of the esophagus into thestomach 36. Accordingly, in clinical practice the positions of points ofengagement 73 and 75 depend on the position of the flap portion 67, sothat positions of points of engagement 73 and 75 and flap portion 67could differ from those illustrated in FIG. 15 by rotation about theopening of the esophagus into the stomach 36 by as much as 180°.Engagement points 73 and 75 are then moved toward each other in thedirection of the arrows shown in FIG. 15, creating a tissue bulge ormound 72. This action can be readily accomplished by a manipulation thatinvolves squeezing. Tissue bulge 72 so created displaces the sealingsurface of valve seat 69 toward the sealing surface of flap portion 67.This manipulated stomach tissue is fixed by deployment of at least onetissue fixation device, in the manner previously described, at tissuefixation point 77 to retain the shape of the tissue bulge 72. The tissuebulge 72 thus established permanently displaces the sealing surface ofvalve seat 69 toward the sealing surface of existing flap portion 67,effectively reconstituting a competent flap valve.

In another preferred embodiment of this method of the invention forremedying this problem, as shown in FIG. 16, stomach tissue is engagedat two points 77 and 79 near the opening of the esophagus into thestomach 36, on the same side of the opening of the esophagus into thestomach 36 as the existing flap portion 67 of gastroesophageal flapvalve 70. The positions of points of engagement 77 and 79 as shown inFIG. 16 are not meant to be limiting. As shown in FIG. 16, the positionsof the points of engagement 77 and 79 and of the flap portion 67 arerelated by their disposition on the same side of the opening of theesophagus into the stomach 36. Accordingly, in clinical practice thepositions of points of engagement 77 and 79 depend on the position ofthe flap portion 67, so that positions of points of engagement 77 and 79and flap portion 67 could differ from those illustrated in FIG. 16 byrotation about the opening of the esophagus into the stomach 36 by asmucn as 180°. Stomach tissue thus engaged at points 77 and 79 ismanipulated to bring them into closer approximation. Such a manipulationcreates a tissue bulge 81 that displaces the sealing surface provided bythe flap portion 67 toward the sealing surface 69 on the opposite sideof the opening of the esophagus into the stomach 36. Manipulated stomachtissue is fixed by deployment of at least one tissue fixation device ata tissue fixation point 83 to retain the shape of the tissue bulge 81.The tissue bulge 81 thus established permanently displaces the sealingsurface provided by the existing flap portion 67 toward the sealingsurface 69 on the opposite side of the opening of the esophagus into thestomach 36, effectively reconstituting a competent flap valve.

In yet another preferred embodiment of this method of the invention forremedying this problem, as shown in FIG. 17, stomach tissue is engagedat two or more pairs of independent points of tissue engagement, onepair defined by points 85 and 87, and another pair defined by points 89and 91, near the opening of the esophagus into the stomach 36. The pairsof points are preferably disposed about the opening of the esophagusinto the stomach 36 as follows: points 87 and 91 are on the same side asthe flap portion 67, and points 85 and 89 are on the side of the openingof the esophagus into the stomach 36 opposite the flap portion 67.Accordingly, in clinical practice the positions of pairs of points ofengagement depend on the position of the flap portion 67, so thatpositions of points of engagement 85, 87, 89, and 91 and flap portion 67could differ from those illustrated in FIG. 17 by rotation about theopening of the esophagus into the stomach 36 by as much as 180°. Pair ofpoints 85 and 87 may be engaged in one step of the method, and pair ofpoints 89 and 91 may be engaged in a separate step of the method. Bothpoints 85 and 87 and points 89 and 91 are independently manipulated inthe direction of arrows 78 to bring points 85 and 87 into closerapproximation, as well as to bring points 89 and 91 into closerapproximation. At least two tissue fixation devices are deployed intostomach tissue at fixation points 93 and 95 in the manner previouslydiscussed to retain the configuration achieved by the manipulationsteps. Points 85 and 87 may be secured in one step of the method, andpoints 89 and 91 may be secured in a separate step of the method. Thesecuring step in FIG. 17 may involve securing manipulated segments oftissue to each other (e.g., point 85 to point 87 and point 89 to point91) or securing each independent manipulated segment to an unmanipulatedportion. Unlike the embodiments above, this embodiment of this methodneed not necessarily result in the creation of a tissue bulge. However,this embodiment of this method also brings into apposition the sealingsurfaces provided by the existing sufficient flap portion 67 and thesealing surface 69 on the opposite side of the opening of the esophagusinto the stomach 36, effectively reconstituting a competent flap valve.

Sufficient Flap Not Present but Sealing Surfaces Adequately Apposed.Creation or Augmention of a Flap.

To remedy a situation where a sufficient flap is not present but thesealing surfaces are adequately apposed, the method already describedwith respect to FIGS. 20 and 21 is used. Stomach lining tissue 16,optionally including at least one underlying layer of stomach wall 34,is engaged at each point 37 and 39 near the opening of the esophagusinto the stomach 36. Each point 37 and 39 must be positioned relative toopening of the esophagus into the stomach 36 so that subsequentmanipulation and fixation steps result in a flap of stomach tissuesuitably located and of sufficient area to cover at least a significantportion of opening of the esophagus into the stomach 36. Stomach tissueengaged at each point 37 and 39 is manipulated in the direction ofarrows 38, i.e., in a direction toward opening of the esophagus into thestomach 36. The manipulations of the two points 37 and 39 shown in FIG.4 may be accomplished sequentially or simultaneously, with the result ofbeing the formation or augmentation of a substantially rectangular flap40, as shown in FIG. 5. Stomach tissue is then secured to flap 40 at twofixation points 35 in the manner described previously, to maintain thesubstantially rectangular shape of the flap 40. The size and tightnessof the flap 46 overlying the opening of the esophagus into the stomach36 will vary based on the location of fixation points 35.

In an alternative embodiment of this method of the invention, shown inFIG. 6, the engagement and manipulation of a single point 41 in thedirection of and across the opening of the esophagus into the stomach 36results in the formation or augmentation of a substantially triangularflap 50. The substantially triangular flap 50 is secured by a singletissue fixation device to stomach tissue at tissue fixation point 51, inthe manner previously described.

FIGS. 18-20 depict yet another alternative embodiment of this method ofthe invention for remedying the problem where there is not a sufficientflap but the sealing surfaces are adequately apposed. Lining tissue 16is engaged at points 37 and 39 near and on one side of the opening ofthe esophagus into the stomach 36 and is invaginated to form arectangular invaginated flap 60 (FIGS. 18 and 19). In the view of FIG.18, the flap 60 is coming up out of the plane of the paper. After theengagement and manipulation steps shown in FIGS. 18 and 20,substantially rectangular flap 60 is fixed at its base with one or moretissue fixation devices 24. In a second step, depicted in FIG. 19, thefree margin of the resulting flap 60 is pulled toward the opposite sideof the opening of the esophagus into the stomach, positioned to coverthe opening of the esophagus into the stomach 36, and fixed to stomachtissue in this position at one or more points 61 opposite the opening ofthe esophagus into the stomach 36 from the fixed base of the flap 60.Two tissue fixation devices each pass through at least two layers ofstomach wall: the layer or layers forming the free margin of the flap 60and at least the lining 16 of the stomach wall near opening of theesophagus into the stomach 36. The size and tightness of the flap dependon the location of points of fixation 61 relative to the base of theflap 60 and the position of the opening of the esophagus into thestomach 36.

Sufficient Flap Not Present and Sealing Surfaces Indequately Apposed:Creation or Augmentation of a Flap Combined with Bringing SealingSurfaces Closer Together.

To remedy a situation where a sufficient flap of tissue is not alreadypresent and the sealing surfaces are not apposed, the stomach isplicated by forming and securing a pair of evaginations by a techniquediscussed below with respect to FIGS. 20-23.

As shown in FIG. 20, an endoscopic tissue engaging and tissue securingdevice 80 is introduced into the lumen 13 of the stomach 10 throughlumen 11 of the esophagus 12. The distal end of the tissue engaging andsecuring device 80 includes a pair of tissue engaging elements 82 and apair of tissue securing device elements 84 each disposed on a rotatablypositionable arm 86. The two tissue securing device elements 84 can betwo aspects of a single device, e.g., one element can be the anvil forthe other. Alternatively, the two tissue securing device elements 84 canbe two independent tissue securing devices unto themselves, e.g., twoone-sided staplers. Motions of the two movable arms 86 can bedependently linked or can be independent of one another. The operatorselects two sites on the lining 16 of the stomach and adjacent toopening of the esophagus into the stomach 36 to be engaged by the twotissue engaging elements 82.

FIG. 21 depicts how, having once engaged tissue at both sites, theoperator then causes the arms 86 of the combination endoscopic tissueengaging device/tissue securing device 80 to swing, thereby creating apair of evaginations 100 straddling the GEJ or distal esophagus. The twoevaginations 100 are then caused to come into apposition, and the twotissue securing device elements 84 deploy at least one tissue fixationdevice to affix one evaginated portion 100 to the other.

FIG. 22 depicts an exterior view of stomach 10 (without the combinationendoscopic tissue engaging device/tissue securing device 80) showingexternal counterparts 97 and 99 to the sites of tissue engagement (whichare within the stomach) and the intended direction of tissuemanipulation, as shown by arrows 88.

As discussed above, fixation is accomplished by placement from the lumen13 of the stomach 10 of at least one tissue fixation device 24 throughat least one full-thickness layer of stomach wall. FIG. 23 depicts anexterior view of stomach 10 following deployment of tissue fixationdevice 24 connecting apposing surfaces of evaginations 100 to create apartial gastric wrap. Tissue fixation device 24 is drawn in broken linesto indicate it is not visible from the outside of the stomach.

In one embodiment of this method, as depicted in FIGS. 20-22 and 24 anddescribed in greater detail below, at least one of evaginations 100 isbrought into contact with and secured to a tissue structure extrinsic tostomach 10. The tissue structure extrinsic to stomach 10 is preferablyan aspect of diaphragm 110. In one particularly preferred embodiment, anaspect of the diaphragm 110 is interposed between evaginations 100 andthe mutual fixation of evaginations 100 with fixation device 24simultaneously fixes the interposed aspect of diaphragm 110 toevaginations 100. Securing of a portion of stomach 10 near the GEJ to arelatively immobile structure extrinsic to stomach 10 creates or assuresan effective barrier to reflux. Hill LD et al. (1990) Gastroenterol ClinNorth Am 19:745-75.

C. Endoscopic Methods for Repairing a Hiatus Hernia

In another aspect, this invention relates to endoscopic methods forrepairing a hiatus hernia. The methods include engaging an aspect of thestomach from within, reducing the hernia (i.e., manipulating a portionof the stomach so engaged to reposition the herniated portion beneaththe diaphragm, manipulating a portion of the stomach so engaged to bringit into contact with an aspect of a tissue structure extrinsic to thestomach, and securing a portion of a stomach to an aspect of a tissuestructure extrinsic to the stomach.

According to a preferred embodiment of this aspect of the invention, thetissue extrinsic to the stomach is an aspect of the diaphragm 110. In amost preferred embodiment the tissue extrinsic to the stomach is themedian arcuate ligament. In other preferred embodiments the tissueextrinsic to the stomach can involve tissue of the right crus, leftcrus, preaortic fascia, hepatogastric ligament, lesser omentum, orgreater omentum.

A preferred method involves evagination, much like the method depictedin FIGS. 20-23, with the additional feature of engaging and fixing anaspect of a tissue structure extrinsic to the stomach between evaginatedportions 100.

Preferably, as shown in FIGS. 20-22 and FIG. 24, although notnecessarily, an aspect of the diaphragm 110 is sandwiched and secured bytissue fixation device 24 between the two evaginations 100 of thestomach wall. The preferred aspect of diaphragm 110 is a portion of themedian arcuate ligament 112. This method achieves the combined effectsof anchoring the stomach 10 to the diaphragm 110, creating a flapelement of a flap valve at the opening of the esophagus into the stomach36, and bringing the sealing surfaces closer together, i.e., shiftingthe tissue at the base of the flap in the direction of the opening ofthe opening of the esophagus into the stomach 36.

An advantage of involving tissue extrinsic to the stomach is thepotential to limit the freedom of movement of at least the securedportion of the stomach relative to some other organ or tissue. Theimportance of this limitation of movement is well recognized in thesurgical treatment of GERD. Hill L D 1989, J Thorac Cardiovasc Surg98:1-10. The classic Hill gastropexy, an open procedure, includesanchoring the GEJ to the median arcuate ligament of the diaphragm,thereby eliminating or at least reducing the mobility of a slidinghiatus hernia.

As in other aspects of this invention, endoscopic visualization may beused for all or any part of the method.

In a preferred embodiment, the at least one tissue fixation device 24makes a through-and-through penetration of the sequential fullthicknesses of stomach 10, entrapped aspect of diaphragm 110, andstomach 10. In another embodiment, the at least one tissue fixationdevice 24 makes both a through-and-through penetration of the fullthicknesses of one face of the stomach 10 and entrapped aspect ofdiaphragm 110, and a partial penetration of the opposing face of stomach10. Fixation can alternatively be effected by (1) applying at least onetissue fixation device 24 through the full thickness of one face of thestomach 10 into at least a partial thickness of the entrapped aspect ofthe diaphragm 110, and (2) applying at least one tissue fixation device101 through the full thickness of a second face of the stomach 10 intoat least a partial thickness of the entrapped aspect of the diaphragm110. Similarly, combinations of full- and partial-thickness bilateralfixations can be employed.

According to another embodiment of this method of the invention, stomach10 and an aspect of the extrinsic tissue structure 110 are brought intoapposition through engagement and invagination of a portion of the inneraspect of stomach 10. Stomach 10 and extrinsic structure 110 are thenfixed together by the application from the lumen 13 of the stomach of atleast one tissue fixation device 24 to penetrate both the stomach and atleast a partial thickness of the extrinsic tissue structure.

In yet another embodiment of this method of the invention, stomach 10and extrinsic tissue structure 110 may already be naturally in desiredapposition. In such applications there may be no need for the engagingand manipulating steps. The stomach and extrinsic structure are thenfixed together by the application from lumen 13 of stomach 10 of atleast one tissue fixation device 24 to penetrate both the stomach and atleast a partial thickness of the extrinsic tissue structure.

D. Instruments and Devices for Endoscopically Reconfiguring TissueWithin a Hollow Organ.

In another aspect this invention relates to novel instruments useful forreconfiguring tissue within a hollow organ in accordance with themethods of this invention. Such instruments may incorporate at least twoof the following aspects: tissue engagement device; tissue manipulationdevice; tissue securing device; and viewing endoscope. In a preferredembodiment, described below, the invention provides a single instrumentcombining a tissue engaging device, tissue manipulation device, andtissue fixation device. A unique feature of this combination instrumentis its ability to manipulate two or more points of tissue in any desireddirection in three dimensional space.

An example of a preferred combination instrument 200 incorporating atissue engagement device and a tissue manipulation device will now bediscussed with reference to FIGS. 25, 26,30, and 32-36.

Instrument 200 includes inner tube 280, concentric outer tube 290, apair of opposable grasper arms 210, grasper arms yoke 220, a pair ofindependent small graspers 250, articulable stapler arms 230, staplerarms yoke 240, stapler cartridge 260 and stapler anvil 270. Instrument200 may be constructed so that it can be sterilized by any method knownin the art, e.g., steam autoclaving, gamma irradiation, and gassterilization. Grasper arms 210 are attached to grasper yoke 220 whichis in turn attached by articulable joint 222 to outer tube 290. Grasperarms 210 are thus able to open and close in order to grasp, as well asto pivot about 180° as a unit relative to the long axis of theinstrument. A pair of torsion springs 216 cause the grasper arms 210 totend to assume an open position in which ends 209 thereof are spaced,and the grasper yoke 220 to tend to assume an off-axis position. Staplerarms 230 are attached to stapler yoke 240 which is in turn attached byarticulable joint 242 to inner tube 280. Stapler arms 230 are thus ableto open and close and to pivot about 180° as a unit relative to the longaxis of the instrument. A pair of torsion springs 236 cause the staplerarms 230 to tend to assume an open position in which cartridge 260 andanvil 270 are spaced from one another, and the stapler yoke assembly 240to tend to assume an on-axis position. The long axis of the instrumentis defined by the concentric axes of inner tube 280 and outer tube 290.Tubes 280 and 290 are constructed so that inner tube 280 can slide androtate within outer tube 290, thus permitting grasper yoke 220 andstapler yoke 240 to move in relation to each other along and about thelong axis of the instrument. Stapler cartridge 260 and stapler anvil 270are disposed near the spaced, distal ends of respective stapler arms230. Cartridge 260 and anvil 270 can be specially structured orstructured according to conventional designs which are well known in theart.

A small grasper 250 is disposed at the end of each stapler arm 230. Asillustrated in FIGS. 25 and 26, each small grasper 250 includes twoopposed, toothed jaws pivotally mounted at one end. Small graspers 250are constructed and activated by a small grasper cable assembly 254 inthe same manner as commercially available endoscopic graspers, forceps,biopsy forceps that are well known in the art.

In a more preferred embodiment, either or both of small graspers 250 aresubstituted with a helical tissue engagement device 300 as depicted inFIG. 27. Helical device 300 has a shape much like a corkscrew andincludes a distal effector end operably connected by a shaft to aproximal controlling end which remains outside the subject when in use.As shown in FIG. 27, the distal end of tissue engaging device 300includes a generally helical spiral 304 having sharpened end 308 andbeing attached to a shaft 306 which is at least somewhat flexible alongits length but sufficiently rigid to transmit a torque to spiral 304 toallow spiral 304 to be screwed into and out of tissue contacted by thesharpened end 308 of spiral 304. Spiral 304 having sharpened end 308 isstructured to engage tissue when turned in one direction and to releasetissue when turned in the opposite direction. Spiral 304 will typicallybe made of titanium, stainless steel, or like material suitable forsurgical instrumentation with a wire diameter of about 0.015″-0.040″. Ina preferred embodiment, spiral 304 wire diameter is 0.025″. Exampledimensions for spiral 304 include radial outside diameter 0.080″-0.250″,and, in a preferred embodiment, 0.120″. Corkscrew-type tissue engagingdevice 300 is advanced through a working channel of an endoscopicinstrument. Alternatively, corkscrew-type tissue engaging device 300 isslidably disposed within an overtube 302 so that the operator can causesharpened end 308 of spiral 304 to protrude beyond and retract withinthe distal end of the overtube 302 by a desired amount. Overtube 302 maybe made of stainless steel, extruded polymer with embedded stainlesssteel braid, polyethylene, polypropylene, polyimide, TEFLON, or similarsuitable biocompatible material. In another alternative, corkscrew-typetissue engaging device 300 is advanced through a working channel of thecombination instrument 200. Such a working channel is a hollow tubesuitable to accommodate a remotely operated surgical tool such ascorkscrew-type tissue engaging device 300, a needle, a grasper, a biopsydevice, a brush, an electrocautery electrode, and the like.

In yet another embodiment, either or both of graspers 250 is substitutedwith suction devices as depicted in FIG. 28. “Suction” as used herein isequivalent to vacuum or reduced pressure, relative to ambientatmospheric pressure. In its simplest embodiment, shown in FIG. 28, thesuction-based tissue engaging device 400 is an open-ended tube 402 withaperture 406 at its distal end 408, tube 402 constructed with sufficientaxial rigidity to resist collapse under the force of an effective vacuumexistent within its lumen 404 when applied end-on to tissue at distalend 408. In another embodiment shown in FIG. 28 the suction-based tissueengaging device 420 is a blind-ended tube 422 with at least one aperture426 in a side wall near distal end 428, tube 422 having sufficient axialrigidity to resist collapse under the force of an effective vacuumexistent within its lumen 404 when applied side-on to tissue. End orside apertures 406 or 426 can include a flange 412. FIG. 28 illustratesone such embodiment 430 in which aperture 406 at distal end 408 ofopen-ended tube 402 opens into flange 412 in fluid communication withlumen 404. Flange 412 can take the shape of a cone, cup, portion of asphere, or otherwise smoothly concave surface. The source of vacuum orreduced pressure can be provided by operative connection at proximal end410 to any means well known in the art, provided the vacuum supplied iseffective for engaging tissue and suitable for the purposes of theinvention. Such means include, without limitation, commerciallyavailable vacuum pumps, “wall suction” available in any hospitaloperating room and in many medical or surgical procedure rooms and manypatient rooms at a hospital, side-arm aspirator, and the like. Reducedpressures suitable for the purposes of the invention typically fallbetween 10 and about 560 mm Hg but may vary with aperture size andshape.

For the purposes of the description which follows, graspers 250 areunderstood to be non-limiting, i.e., corkscrew-like retractors 300 orsuction devices 400 can be used to similar effect.

As shown in FIG. 26, cable assembly 214 is coupled to grasper arms 210and, together with grasper arms torsion springs 216 causes grasper arms210 to open and close. Tensioning grasper arms cable assembly 214counteracts grasper arms torsion springs 216 to cause grasper arms 210to close; relaxing grasper arms cable assembly 214 permit grasper armstorsion springs 216 to cause the grasper arms 210 to open. Similarly,cable assembly 234 is coupled to stapler arms 230, and together withstapler arms torsion springs 236 cause to permit stapler arms 230 toopen and close. Tensioning stapler arms cable assembly 234 counteractsstapler arm torsion springs 236 to cause stapler arms 230 to close;relaxing stapler arms cable assembly 234 permits stapler arms torsionsprings 236 to cause stapler arms 230 to open.

Stapler cartridge 260 is disposed on the end of one stapler arm 230 andis activated by cable assembly 264 to deploy at least one staple intotissue. Stapler anvil 270 disposed on the distal end of the otherstapler arm 230 and stapler cartridge 260 are brought into apposition bytensioning stapler arms cable assembly 234.

In an alternative embodiment, stapler cartridge 260 and stapler anvil270 are substituted with corresponding elements structured to deliver atleast one two-part fastener as described above. An example of apreferred embodiment of a two-part fastener is shown in FIG. 29. Thefastener includes a first part 350 and a second part 360. First part 350includes a head 352 and a post 354 having a conical end which tapers toa point 356 capable of piercing tissue. Second part 360 is an annularretainer 362 structured to engage post 354 with retainer slotted flange364 when point 356 is advanced through retainer aperture 366. Slottedflange 364 includes a plurality of rigid radially extending flaps whichalso extend axially away from head 352 on one side of aperture 366.Flaps of slotted flange 364 allow post 354 to be inserted throughaperture 366 from the other side of aperture 366, but prevent withdrawalof post 354 once inserted. Flaps of slotted flange 364 bend radiallyoutwardly to accommodate post 354, the diameter of which otherwiseexceeds the aperture 366, thus causing slotted flange 364 to engage andretain post 354. The length of post 354 is sufficient to penetratethrough the desired amount or depth of tissue and to permit engagementby retainer 362 for the application for which it is used. Typically,such length will be ca. 0.25 inches. In a preferred embodiment thegreatest outside diameter of head 352 or retainer 362 is ca. 0.250inches. Post 354 can be grooved or threaded, e.g., with an 0-80 threadto provide a more secure engagement with slotted flange 364. Parts 350and 360 preferably are made of titanium, stainless steel, biocompatiblepolymer, or a combination of such materials. For the purposes of thedescription which follows, stapler cartridge 260 and stapler anvil 270are understood to be non-limiting, i.e., elements structured to deliverat least one two-part fastener could be used to similar effect.

As shown in FIG. 30, grasper arms yoke cable assembly 224 and grasperarms yoke torsion spring 228 are coupled to grasper arms yoke 220.Grasper arms yoke 220 and grasper arms 210 pivot about articulable joint222. Tensioning of grasper arms yoke cable assembly 224 counteracts thegrasper arms yoke torsion spring 228 to cause the grasper arms yoke 220to pivot so that the free ends 209 of grasper arms 210 pivot away fromstapler arms yoke 240; relaxing of grasper arms yoke cable assembly 224permits grasper arms yoke torsion spring 228 to cause the grasper armsyoke 220 to pivot so that the free ends 209 of grasper arms 210 pivottoward the stapler arms yoke 240.

Similarly, stapler arms yoke cable assembly 244 and stapler arms yoketorsion spring 248 are coupled to stapler arms yoke 240. Yoke 240 pivotsabout an articulable joint 242. Tensioning of stapler arms yoke cableassembly 244 counteracts stapler arms yoke torsion spring 248 to causethe stapler arms yoke 240 to pivot so that the free ends of stapler arms230 pivot toward grasper arms yoke 220; relaxing of stapler arms yokecable assembly 244 permits stapler arms yoke torsion spring 248 to causestapler arms yoke 240 to pivot so that the free ends of grasper arms 230pivot away from grasper arms yoke 220.

An optional feature of instrument 200 shown in FIG. 31 is the inclusionof at least one of pressure monitoring tubes 500 and 520. Tube 500includes at least one opening 506 positioned in the vicinity of thegrasper arms yoke 220 and permits measurement of tissue pressure at theGEJ when instrument 200 is advanced into position as previouslydescribed. The proximal end of tube 500 is operably connected to amanometer outside the subject. Tube 520 includes at least one opening506 positioned anywhere along stapler arms 230 and permits measurementof yield pressure when instrument 200 is advanced into position aspreviously described. The proximal end of tube 520 is operably connectedto a manometer outside the subject. Tubes 500 and 520 are preferablymade of a biocompatible polymer and are structured to have an insidediameter of at least ca. 0.020 inches. Tube 500 terminates as ablind-ended tube at its distal end 504 and has an opening 506 in itsside wall near distal end 504. Tube 520 may also terminate as ablind-ended tube at its distal end 504 and has an opening 506 in itsside wall near distal end 524. Alternatively, tube 520 may terminate asan open-ended tube at distal end 524.

Measurement of the tissue pressure at the GEJ, the yield pressure, orboth pressures assists the operator in determining where to engage,manipulate, and/or secure tissue to greatest advantage. Pressuremeasurements can be taken at any point throughout the procedure. Forexample, an operator performing any of the described methods fortreating GERD can take a baseline measurement of at least one of thesepressures, engage and manipulate tissue, take another measurement,disengage tissue, and then repeat at least the steps of engaging,manipulating, and measuring, until a desired pressure is obtained.Likewise, an operator performing any of the described methods fortreating GERD can take a baseline measurement of at least one of thesepressures, engage and manipulate tissue, take another measurement,disengage tissue, and then repeat at least the steps of engaging,manipulating, and measuring, to determine an optimal location ofengagement, an optimal manipulation, and/or an optimal point offixation.

When instrument 200 is used for the methods of this invention, thedistal end of instrument 200, including stapler arms 230, stapler armsyoke 240, grasper arms yoke 220, and grasper arms 210, is introducedinto stomach 10 of a subject via a conduit which may be esophagus 12 ora gastrostomy. During the introduction of the instrument into thestomach, the instrument is positioned as shown in FIG. 25. Whenpositioned as shown in FIG. 25, the entire distal end of instrument 200is structured to pass through a hole less than about one inch indiameter, and more preferably, through a hole no more than 2.0 cm indiameter. Next, stapler arms yoke 240 is rotated by tensioning staplerarms yoke cable assembly 244, stapler arms 230 are opened by relaxingstapler arms cable assembly 234, and inner tube 280 is advanced withinouter tube 290. The instrument thus assumes the configuration shown inFIG. 32.

The two small graspers 250 engage tissue at two independent points.Tissue so engaged can be manipulated simply by tensioning stapler armscable assembly 234, to bring the two small graspers 250 into closerproximity. Such manipulation can be used to create a mound of tissue byeffectively squeezing tissue interposed between the two small graspers250. Such an operation may be useful in bringing sealing surfaces closertogether to tighten an existing flap valve, such as in FIGS. 15 and 17.In FIG. 15, small graspers 250 engage tissue at points 73 and 75 andstapler arms 230 are brought into closer approximation by tensioningstapler arms cable assembly 234 to create a mound of tissue 72 adjacentto the existing flap valve 70. At least one staple is deployed bystapler cartridge 260 into the tissue at location 77 to stabilize thetissue reconfiguration. Similarly in FIG. 17, small graspers 250 engagetissue at first pair of points 89 and 91 (or 85 and 87) and stapler arms230 are brought into closer approximation by tensioning stapler armscable assembly 234 to bring points 89 and 91 (or 85 and 87) into closerapproximation. At least one staple is deployed by cartridge 260 into thetissue at respective location 93 (or 95) to stabilize the tissuereconfiguration. These steps are then repeated with respect to the otherpair of points.

The two small graspers 250 can evaginate tissue by sliding the staplerarms yoke 240 in the direction of the desired evagination, such as shownin FIG. 17. Grasper arms 86 correspond to stapler arms 230; associatedsmall graspers 82 to small graspers 250; and stapler elements 84 tostapler cartridge 260 and stapler anvil 270.

Small graspers 250 also may be used to advantage in combination withgrasper arms 210. After introduction of the distal end of instrument 200into the lumen of the stomach and assumption of configuration shown inFIG. 32 as above, FIG. 33 shows small graspers 250 and grasper arms 210are opened and ready to be brought into contact with tissue. Followingtissue contact, FIG. 34 shows grasper arms 210 closed to engage tissuenear opening of esophagus into stomach 36, while small graspers 250 areclosed to engage tissue at points that will be moved to create aplication, as shown in FIG. 22. As shown in FIG. 35, tissue so engagedcan be manipulated by any combination of pivoting grasper arms 210,pivoting stapler arms 230, and positioning grasper arms yoke 220relative to stapler arms yoke 240. In a preferred embodiment, staplerarms 230 are closed and stapler arms yoke 240 is pivoted as required tobring tissue together around the distal esophagus, creating a plication,as shown in FIG. 36.

Another embodiment of a tissue engaging and manipulating device 600 isillustrated with respect to FIG. 37. Device 600 includes a conventionalendoscope 602 onto which or in conjunction with which a roller assembly604 is mounted. Roller assembly 604 includes a pair of rollers 606 and607 which are each independently journalled for free rotation on a pairof support arms 608. Support arms 608 in turn are fixed to supportstructure 610 which is coupled to endoscope 602. Each roller 606 and 607includes teeth 612. Teeth 612 of one roller 606 preferably interengageteeth 612 of the other roller 607. However, in an alternativeembodiment, the ends of teeth 612 on each roller 606 and 607 could bespaced a very small distance from one another. Preferably, teeth 612extend from rollers 606 and 607 at an angle with respect to a radius ofrollers 606. However, teeth 612 could extend radially. Rollers 606 and607 rotate in opposite directions from one another. In other words,while roller 606 would rotate in a clockwise direction as shown in FIG.37, roller 607 would rotate in a counter-clockwise direction, as shownin FIG. 37. In this way, tissue engaged by rollers 606 and 607 would becaptured and drawn between rollers 606 and 607 to form a flap, bulge,mound or the like. Preferably, the direction of rotation of rollers 606and 607 could be reversed to release tissue once fixation of the tissuehad been obtained. Alternatively, support structure 610 can bestructured so as to permit rollers 606 and 607 to disengage by swingingapart from one another. At least one of rollers 606 and 607 is driven byan externally disposed hand-operated mechanism or servo motor (notshown) which is coupled to each driven roller 606 and/or 607 by asuitable cable (not shown).

In operation, the combined endoscope and device 600 is deployedendoscopically into a subject's stomach. Utilizing viewing endoscope602, device 604 is positioned to engage tissue at a desirable locationwithin the stomach or other organ. Once placed in the desired location,the hand-operated mechanism or servo motor (not shown) is activated torotate rollers 606 and 607 to engage and manipulate the tissue to adesired size and shape. Thereafter, rotation of rollers 606 and 607 isdiscontinued. A suitable fixation device (not shown) is deployedendoscopically to fix the resulting reconfigured tissue in itsreconfigured shape. The tissue fixation device utilized is one of thosepreviously described with respect to this invention, including aconventional stapler. Upon completion of the fixation step, thedirections of rotation of rollers 606 and 607 are reversed to releasethe tissue from rollers 606 and 607. Thereafter, device 600 may be movedto a different location within the stomach or other organ and the stepsdescribed above may be repeated.

Since the device of the present invention is novel and it is intended tobe used in treating a human subject, it is important that the physicianoperator be instructed to use the device mechanisms and methodsdisclosed herein. The training of the device and method may beaccomplished on a cadaver or a human model, or it may be accomplished atthe bedside of a patient.

Equivalents

Those skilled in the art will recognize, or be able to ascertain usingno more than routine experimentation, many equivalents to the specificembodiments of the invention described herein. Such equivalents areintended to be encompassed by the following claims.

1. A tissue shaping instrument comprising a proximal controlling end; adistal effector end; an elongated portion connecting the distal effectorend to the proximal controlling end, the elongated portion being ofsufficient length to enable an operator to access an interior of ahollow organ of a subject with the distal effector end while theproximal controlling end remains outside of the subject; a first tissueengaging device disposed on the distal effector end and operablyconnected to the proximal controlling end, the first tissue engagingdevice being structured for releasably engaging at least the innersurface of the hollow organ and for manipulating tissue thus engaged; asecond tissue engaging device also disposed on the distal effector endand operably connected to the proximal controlling end, the secondtissue engaging device being structured for (a) releasably engaging theinterior of the hollow organ, and (b) moving relative to the firsttissue engaging device, wherein the controlling end of the instrument isstructured to actuate the tissue engaging device.
 2. The tissue shapinginstrument of claim 1, wherein the instrument is an endoscopicinstrument.
 3. The tissue shaping instrument of claim 1, furthercomprising a tissue securing device disposed at the distal effector endand operably connected to the proximal controlling end.
 4. The tissueshaping instrument of claim 3, wherein at least one tissue fixationdevice is configured to be loaded into the tissue securing device by aperson using the device.
 5. A tissue shaping instrument comprising aproximal controlling end; a distal effector end; an elongated portionconnecting the distal effector end to the proximal controlling end, theelongated portion being of sufficient length to enable an operator toaccess an interior of a hollow organ of a subject with the distaleffector end while the proximal controlling end remains outside of thesubject; a first tissue engaging device disposed on the distal effectorend and operably connected to the proximal controlling end, the firsttissue engaging device being structured for releasably engaging at leastthe inner surface of the hollow organ and for manipulating tissue thusengaged so as to reconfigure a portion of at least the interior of thehollow organ; a second tissue engaging device also disposed on thedistal effector end and operably connected to the proximal controllingend, the second tissue engaging device being structured for (a)releasably engaging the interior of the hollow organ and formanipulating tissue thus engaged so as to reconfigure a portion of theinterior of at least the interior of the hollow organ, (b) movingrelative to the first tissue engaging device, and (c) workingcooperatively with a tissue securing device; and a tissue securingdevice disposed at the distal effector end and operably connected to theproximal controlling end, wherein the tissue securing device iseffective for fixing tissue of the hollow organ reconfigured by at leastone of the first tissue engaging device and the second tissue engagingdevice, wherein the controlling end of the instrument is structured toactuate the tissue engaging device and the tissue securing device. 6.The instrument of claim 5 wherein the instrument is an endoscopicinstrument.
 7. The tissue shaping instrument of claim 5 wherein eitheror both the first tissue engaging device and the second tissue engagingdevice comprises a jawed clamp.
 8. The tissue shaping instrument ofclaim 5 wherein at least one of the first tissue engaging device and thesecond tissue engaging device comprises a corkscrew-like retractor. 9.The tissue shaping instrument of claim 5 wherein the tissue securingdevice comprises a stapler.
 10. The tissue shaping instrument of claim 9wherein the stapler comprises a one-sided stapler.
 11. The tissueshaping instrument of claim 5 wherein the tissue securing devicecomprises a device structured for delivering at least one biocompatibletissue fixation device into a tissue.
 12. The tissue shaping instrumentof claim 11 wherein the at least one tissue fixation device is selectedfrom the group consisting of a staple, a clip, a tack, a rivet, atwo-part fastener, a helical fastener, a suture, and a T-bar suture. 13.The tissue shaping instrument of claim 11 wherein the at least onetissue fixation device is a staple.
 14. The tissue shaping instrument ofclaim 11 wherein the at least one tissue fixation device is a two-partfastener.
 15. The tissue shaping instrument of claim 11 wherein the atleast one tissue fixation device is a suture.
 16. The tissue shapinginstrument of claim 11 wherein the at least one tissue fixation deviceis a T-bar suture.
 17. The tissue shaping instrument of claim 5 whereineither or both the first tissue engaging device and the second tissueengaging device is non-piercing.
 18. The tissue shaping instrument ofclaim 5 wherein at least part of the elongated portion is flexible. 19.The tissue shaping instrument of claim 5 further comprising a viewingendoscope.
 20. The tissue shaping instrument of claim 5 furthercomprising at least one working channel.
 21. The tissue shapinginstrument of claim 5 wherein the instrument is sterilized.
 22. A tissueengaging device comprising a proximal controlling end; a distal effectorend; and an elongated portion connecting the distal effector end to theproximal controlling end, the elongated portion being of sufficientlength to enable an operator to access an interior of a hollow organ ofa subject with the distal effector end while the proximal controllingend remains outside of the subject; wherein the distal effector endcomprises a helix with a sharpened end structured to be reversiblyscrewed into and out of a tissue brought into in contact with thesharpened end, and wherein the controlling end of the tissue engagingdevice is structured to actuate the tissue engaging device.
 23. Thetissue engaging device of claim 22 wherein the device is an endoscopicdevice.
 24. Apparatus comprising: means for transorally engaging aplurality of regions of stomach tissue with a plurality of members fromwithin the stomach, at least one of the members configured to movetoward another member to reconfigure tissue, and means for pullingtissue located between the plurality of regions of tissue prior toengaging the plurality of regions of tissue.
 25. The apparatus of claim24 wherein the plurality of members include a first member having afirst securing part configured to engage a first tissue section and asecond member having a second securing part configured to engage asecond tissue section.
 26. The apparatus of claim 24 wherein theengaging means includes a corkscrew element.
 27. The apparatus of claim24 wherein the engaging means includes a clamping device.
 28. Theapparatus of claim 24 wherein the engaging means includes a suctiondevice.
 29. The apparatus of claim 24 wherein the engaging meansincludes a grasping device.
 30. The apparatus of claim 24 furthercomprising a means for securing the reconfigured tissue.
 31. Theapparatus of claim 30 wherein the securing means includes one or moreof: a staple, a clip, a tack, a rivet, a two-part fastener, a helicalfastener, a suture, a T-bar suture, and a tissue adhesive.
 32. Theapparatus of claim 30 wherein the securing means is biocompatible. 33.The apparatus of claim 30 wherein the securing means is non-resorbable.34. Apparatus comprising: an elongated member configured for transoralplacement in the stomach and having a distal region including first andsecond movable members configured to be moved toward one another toreconfigure stomach tissue, the distal region being steerable as a unit,and means for deploying an implant from at least one of the members tosecure the reconfigured tissue.
 35. The apparatus of claim 34 whereinthe first movable member includes a first securing part configured toengage a first tissue section and the second movable member includes asecond securing part configured to engage a second tissue section. 36.The apparatus of claim 34 wherein the elongated member includes acorkscrew element.
 37. The apparatus of claim 34 wherein the elongatedmember includes a clamping device.
 38. The apparatus of claim 34 whereinthe elongated member includes a suction device.
 39. The apparatus ofclaim 34 wherein the elongated member includes a grasping device. 40.The apparatus of claim 34 wherein the deploying means includes a distalend effector configured to contact the reconfigured stomach tissue. 41.The apparatus of claim 40 wherein the distal end effector includes atleast one tissue fixation device.
 42. The apparatus of claim 41 whereinthe distal end effector is configured for application of the at leastone tissue fixation device into the reconfigured stomach tissue.
 43. Theapparatus of claim 40 further comprising a means for controlling thedistal end effector.
 44. The apparatus of claim 43 wherein thecontrolling means is disposed at a proximal end of the apparatus and isoperatively connected to the distal end effector.